about
Adding fuel to the fire: immunogenic intensification.PARP Inhibitors in Reproductive System Cancers: Current Use and Developments.Clinical experience with ramucirumab : outcomes in breast cancer.Class act: safety comparison of approved tyrosine kinase inhibitors for non-small-cell lung carcinoma.MABp1 for the treatment of colorectal cancer.Curcumin induces apoptosis-independent death in oesophageal cancer cells.Effectiveness and safety of eribulin mesylate: a new therapeutic option in the treatment of metastatic breast cancer.Hidradenitis suppurativa-like lesions associated with pharmacologic inhibition of gamma-secretase.Impact of age on antigen-specific T lymphocyte response in patients treated with PSA-TRICOMA Phase I Study of Ganetespib and Ziv-Aflibercept in Patients with Advanced Carcinomas and Sarcomas.Cediranib phase-II study in children with metastatic alveolar soft-part sarcoma (ASPS)Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymomaImmune play: defending the liverA phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunctionNivolumab: promising survival signal coupled with limited toxicity raises expectations
P50
Q35886393-D6510FFF-0AE6-435E-828F-01F70195AE67Q37607283-4195171D-F28D-4422-8A4F-01E746744DA8Q38228982-FC450C1F-54B8-47BF-9E47-D33E66CBA021Q38262804-6108744F-6EA7-4742-8A0B-EF78E0F3DB5BQ38686881-CFB14EAC-521A-41A9-8229-6BEBDEE6053EQ39790538-E1AAC818-2B38-4061-B9D1-53576F7C8E8EQ47628083-6790762A-E272-4C71-AC89-64D3C4966AB9Q50017263-97304F6B-BAE3-4EFD-8650-84EC7421E90DQ59400441-199788BB-E03F-4EB3-9349-2965CF9DE910Q64926357-16504A43-9DB0-47FC-BD01-D4DBCF0D9FC2Q90012146-41EE9721-4529-4225-BDD8-B30FBB8C5848Q90872506-764D93C9-0450-4104-9BB1-BD144D644EB2Q91323722-5C2D0586-51D0-4C22-AD46-14C029E3D0DFQ91604096-37788F52-A5AD-40DF-8866-AFCB9A46369FQ94535675-05EDE6CA-6EE4-45D4-9CEC-9B36F024C8FF
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Geraldine O'Sullivan Coyne
@en
Geraldine O'Sullivan Coyne
@nl
type
label
Geraldine O'Sullivan Coyne
@en
Geraldine O'Sullivan Coyne
@nl
prefLabel
Geraldine O'Sullivan Coyne
@en
Geraldine O'Sullivan Coyne
@nl
P31
P496
0000-0002-2918-6326